Clinical Trials Browser

Phase 1/2 × OTHER × magrolimab × Clear all

NCT04435691 2025-04-27

Magrolimab, Azacitidine, and Venetoclax for the Treatment of Acute Myeloid Leukemia

Phase 1/2 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute